APPLIED STEMCELL, INC.

Applied StemCell, Inc. specializes in the design, generation, and evaluation of genetically engineered mouse models and cell line systems for biomedical research, leveraging CRISPR/Cas9 gene editing and advanced molecular biology techniques. Their core capabilities include conditional knockout model development, targeted mutagenesis, and functional validation of disease-associated genes such as GRIN2A, with expertise in transgenic model validation, phenotypic screening, and laboratory-scale biotechnology R&D. The firm distinguishes itself through precision genome engineering workflows, rigorous cell line characterization, and end-to-end support for preclinical research initiatives, serving as a trusted partner for complex genetic modeling needs in academic and government laboratories. The company maintains a strong, consistent relationship with the Department of Health and Human Services, delivering specialized biotechnology services that support genetic disease research, neurodevelopmental disorder studies, and translational science programs. Their work for HHS typically involves the creation of genetically defined animal models and cellular assays critical for understanding gene function and therapeutic targeting, reflecting a pattern of recurring engagement on high-precision, mission-critical projects. Applied StemCell operates primarily within NAICS 541714 (biotechnology R&D), 541380 (testing laboratories), and 541990 (other professional scientific services), positioning itself as a niche provider of custom genetic model development and functional genomics support. They serve the biomedical research vertical with a focus on preclinical discovery, offering tailored solutions that bridge molecular design and biological validation. As a Women-Owned Small Business and Woman-Owned Business certified firm based in Milpitas, California, Applied StemCell brings a lean, agile structure to federal research contracting, combining technical rigor with compliance-driven project execution. Their certifications enhance their accessibility within federal small business set-aside programs, reinforcing their role as a mission-aligned partner in advancing public health science.